LOX and breast cancer: In vivo, MIA PaCa-2 pancreatic cancer and NF639 breast cancer cells showed reduce tumour weight after injection into nude mice followed by injection of recombinant LOX pro-peptide [134], or when infected with a LOX pro-peptide over-expressing virus [136,138].